Oligodendroglioma
What's New
Last Posted: Aug 27, 2022
- Prognostic risk stratification of gliomas using deep learning in digital pathology images.
Chunduru Pranathi et al. Neuro-oncology advances 2022 4(1) vdac111 - Subtyping and grading of lower-grade gliomas using integrated feature selection and support vector machine.
Munquad Sana et al. Briefings in functional genomics 2022 - Multi-institutional study of the frequency, genomic landscape and outcome of IDH-mutant glioma in paediatrics.
Yeo Kee Kiat et al. Neuro-oncology 2022 - Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances.
Hasanau Tsimur et al. Biomedicines 2022 10(3) - Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma.
Satomi Kaishi et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 Oct - Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.
Dono Antonio et al. Journal of neuro-oncology 2020 Oct - The Evaluation of Radiomic Models in Distinguishing Pilocytic Astrocytoma From Cystic Oligodendroglioma With Multiparametric MRI.
Zhao Yajing et al. Journal of computer assisted tomography 2020 Sep - Segmentation and Classification in Digital Pathology for Glioma Research: Challenges and Deep Learning Approaches.
Kurc Tahsin et al. Frontiers in neuroscience 2020 1427 - Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma.
Rosenberg Shai et al. The oncologist 2018 23(12) 1500-1510 - Diffuse gliomas in patients aged 55 years or over: A suggestion for IDH mutation testing.
Barresi Valeria et al. Neuropathology : official journal of the Japanese Society of Neuropathology 2019 Nov
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: